Canada’s Drug Agency (CDA-AMC)
In December 2023, it was announced that Canada’s Drug Agency would be built from CADTH. The work of the drug agency expands on CADTH’s existing mandate and functions — which spans drugs, medical devices, and clinical interventions — and includes new work streams such as:
- improving the appropriate prescribing and use of medications
- increasing pan-Canadian data collection and expanding access to drug and treatment data, including real-world evidence data
- reducing drug system duplication and lack of coordination
CADTH adopted the new name Canada’s Drug Agency (CDA-AMC) as of May 1, 2024. An official launch will occur later this year.
Are You the Next Scientific Director of CIHR’s Institute of Cancer Research?
As you know, the CIHR-ICR funds cancer research in Canada based on internationally accepted standards of excellence with the goal of reducing the burden of cancer on individuals and is dedicated to creating and maintaining a robust cancer research environment in Canada. This positi... Read More »
As you know, the CIHR-ICR funds cancer research in Canada based on internationally accepted standards of excellence with the goal of reducing the burden of cancer on individuals and is dedicated to creating and maintaining a robust cancer research environment in Canada. This positi... Read More »